• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

No Picture
Stock News

Deloitte partner scams colleagues and others for $60m

February 17, 2023 admin 0

The full email from Deloitte boss Adam Powick: Hi Partners, It’s been an interesting 48 hours after the news broke of an allegedly fraudulent investment led by one of our ex partners, Amberjit Endow. It […]

Stock News

Nutrien Earnings: Guidance? Cautious, But That’s OK (NYSE:NTR)

February 17, 2023 admin 0

fotokostic/iStock via Getty Images Investment Thesis Nutrien (NYSE:NTR) is cheaply valued, but there’s more to this story than just a low valuation. On one hand, NTR is priced at 8x this year’s EPS. And that’s […]

No Picture
Stock News

Elme Communities (ELME) Q4 2022 Earnings Call Transcript

February 17, 2023 admin 0

Elme Communities (NYSE:ELME) Q4 2022 Earnings Conference Call February 17, 2023 10:00 AM ET Company Participants Amy Hopkins – Vice President, Investor Relations Paul McDermott – President and Chief Executive Officer Steve Riffee – Executive […]

Posts navigation

« 1 … 245 246 247 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Your Cash Is Trash: 2 REITs That Should Soar With Inflation
    July 18, 2022 0
  • Europe’s STOXX 600 opens higher after three-day selloff; Nexi shines By Reuters
    September 27, 2022 0
  • Teradata Earnings: Cloud Gains Momentum, FCF To Shareholders (NYSE:TDC)
    February 13, 2023 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.